MENU
+Compare
MGTX
Stock ticker: NASDAQ
AS OF
Dec 18, 04:59 PM (EDT)
Price
$5.84
Change
-$0.56 (-8.75%)
Capitalization
500.18M

MGTX MeiraGTx Holdings plc Forecast, Technical & Fundamental Analysis

a developer of novel treatments for inherited and acquired genetic disorders

Industry Biotechnology
MGTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
a Summary for MGTX with price predictions
Dec 17, 2024

MGTX sees its 50-day moving average cross bullishly above its 200-day moving average

The 50-day moving average for MGTX moved above the 200-day moving average on November 15, 2024. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 71 cases where MGTX's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on December 17, 2024. You may want to consider a long position or call options on MGTX as a result. In of 100 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where MGTX advanced for three days, in of 254 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 125 cases where MGTX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for MGTX moved out of overbought territory on November 14, 2024. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 17 similar instances where the indicator moved out of overbought territory. In of the 17 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Moving Average Convergence Divergence Histogram (MACD) for MGTX turned negative on November 15, 2024. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MGTX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. MGTX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.126) is normal, around the industry mean (14.664). P/E Ratio (0.000) is within average values for comparable stocks, (87.689). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.783). MGTX has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.012). P/S Ratio (29.586) is also within normal values, averaging (260.687).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MGTX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
MGTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

MGTX is expected to report earnings to rise 3.64% to -56 cents per share on March 12

MeiraGTx Holdings plc MGTX Stock Earnings Reports
Q4'24
Est.
$-0.57
Q3'24
Beat
by $0.01
Q2'24
Missed
by $0.36
Q1'24
Beat
by $0.09
Q4'23
Beat
by $0.38
The last earnings report on November 13 showed earnings per share of -55 cents, beating the estimate of -56 cents. With 212.40K shares outstanding, the current market capitalization sits at 500.18M.
A.I. Advisor
published General Information

General Information

a developer of novel treatments for inherited and acquired genetic disorders

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
450 East 29th Street
Phone
+1 646 860-7985
Employees
425
Web
https://www.meiragtx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SEVIX16.47N/A
N/A
SEI US Managed Volatility I (SIMT)
BEQAX34.50-0.13
-0.38%
American Century Equity Growth A
JAGIX70.93-0.27
-0.38%
Janus Henderson Growth And Income T
WSMGX21.36-0.19
-0.88%
Wilshire Small Company Growth Instl
MMSIX12.69-0.17
-1.32%
Praxis Small Cap Index I

MGTX and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, MGTX has been loosely correlated with NTLA. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if MGTX jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MGTX
1D Price
Change %
MGTX100%
+1.91%
NTLA - MGTX
51%
Loosely correlated
-1.87%
BEAM - MGTX
50%
Loosely correlated
-1.21%
ABOS - MGTX
49%
Loosely correlated
-0.51%
ABCL - MGTX
46%
Loosely correlated
-2.45%
CRBU - MGTX
46%
Loosely correlated
+1.57%
More